Ginseng (Panax) for Blood Sugar Regulation

Research suggests that Panax ginseng and its active compounds, particularly ginsenosides, may support blood sugar regulation through multiple biological pathways, including improved insulin secretion, enhanced cellular glucose uptake, activation of metabolic signaling pathways such as AMPK and PI3K/AKT, and favorable shifts in gut microbial populations. The available evidence spans a 2019 review of cell, animal, and human studies, a 2025 systematic review of 102 studies, several animal model experiments, and at least one meta-analysis, with the body of work leaning broadly supportive — though most mechanistic findings come from preclinical models and have not been fully confirmed in human clinical trials. Studies indicate that benefits appear most pronounced in people with type 2 diabetes, with one review noting roughly a 15% reduction in fasting blood sugar in diabetic patients, while the same review found no significant effect in individuals with prediabetes or healthy adults, reflecting an important limitation in how broadly these findings can be applied. Overall, the research base is promising but still developing, with variability in ginseng preparations, doses, and study quality making it difficult to draw firm conclusions about consistent effects in humans.